- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07852468
Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer (COPES Aim 3)
This is a Stage 1 study of a behavioral intervention, which means that a new intervention is being pilot tested to understand whether it is acceptable and feasible for people with advanced cancer to use. The purpose of this study is to evaluate whether a series of 3 10-minute videos may help improve prescription opioid pain management and opioid stigma for people living with advanced cancer. Approximately 45 participants will take part in this study at the University of Alabama at Birmingham. People who choose to participate in this study will complete a series of baseline questionnaires, and then will be randomized to one of two groups: 1) the group that gets the video intervention, or 2) the group that gets a written handout with information about cancer pain. About 4 weeks later, all participants will also be asked to fill out another series of questionnaires.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Cyrah Finley
- Telefonnummer: 205-996-2030
- E-post: cyrahfinley@uabmc.edu
Studer Kontakt Backup
- Navn: Erin Hornsby
- Telefonnummer: 205-975-2912
- E-post: eehornsby@uabmc.edu
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35294
- University of Alabama at Birmingham
-
Ta kontakt med:
- Cyrah Finley
- Telefonnummer: 205-996-2030
- E-post: cyrahfinley@uabmc.edu
-
Ta kontakt med:
- Erin Hornsby
- Telefonnummer: 205-975-2912
- E-post: eehornsby@uabmc.edu
-
Hovedetterforsker:
- Hailey W Bulls, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- age ≥ 18 years old
- speaks English
- current, advanced solid tumor cancer diagnosis (stage III or IV)
- endorses cancer-related pain (e.g,. pain, that began, worsened, and/or changed during cancer)
- current opioid prescription OR planning to initiate opioids for cancer pain management
Exclusion Criteria:
- observable psychiatric disorders that would interfere with study participation (e.g., dementia, psychosis)
- inability to speak and read English
- inability to provide informed consent
- prior participation in aspects of this study (i.e., K08 Aims 1 and 2)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Cancer Pain 101 Intervention
Participants randomized to the intervention group will have access to three 10-minute videos through a digital application. The videos cover cancer pain, pain medications, and pain self-management skills, and will be available for four weeks. |
The study intervention is Cancer Pain 101. Cancer Pain 101 is a 3-part educational video series, designed to be delivered asynchronously. Each video is approximately 10 minutes long and is narrated by a multidisciplinary team, including a psychologist, oncologist, palliative care clinician, and pharmacist. |
|
Ingen inngripen: Educational Control
Participants in the educational control condition will receive a written handout about cancer pain, which is widely available and published by the American Cancer Society; they will not have access to the intervention videos. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of participants who watch at least one video
Tidsramme: 4 weeks
|
Count participants who watch at least one video |
4 weeks
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Hailey W Bulls, PhD, University of Alabama at Birmingham
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Bulls HW, Hamm M, Wasilko R, de Abril Cameron F, Belin S, Goodin BR, Liebschutz JM, Wozniak A, Sabik LM, Merlin JS, Schenker Y. Manifestations of Opioid Stigma in Patients With Advanced Cancer: Perspectives From Patients and Their Support Providers. JCO Oncol Pract. 2022 Oct;18(10):e1594-e1602. doi: 10.1200/OP.22.00251. Epub 2022 Jul 25.
- Bulls HW, Chu E, Goodin BR, Liebschutz JM, Wozniak A, Schenker Y, Merlin JS. Framework for opioid stigma in cancer pain. Pain. 2022 Feb 1;163(2):e182-e189. doi: 10.1097/j.pain.0000000000002343.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- STUDY00000160
- K08CA263317 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
The proposed research will include data from a total of 120 patients (75 Aims 1 and 2; 45 Aim 3) with advanced cancer. The final dataset will include self-reported demographic data and survey data from pilot trial assessments. All data in our analysis will be deidentified. No identifying information will be retained past the conclusion of the K08 study period. The data collected will be used for publication purposes and will be made available for public use upon completion of our study and the initial dissemination of our research results. Any data shared will be de-identified.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .